ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 97 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $498,295 | -33.4% | 74,595 | -16.4% | 0.00% | – |
| Q2 2023 | $748,631 | +1076.5% | 89,229 | +1292.5% | 0.00% | – |
| Q1 2023 | $63,631 | +407.9% | 6,408 | +256.0% | 0.00% | – |
| Q4 2022 | $12,528 | -90.9% | 1,800 | -93.0% | 0.00% | – |
| Q3 2022 | $138,000 | -95.5% | 25,803 | -96.6% | 0.00% | -100.0% |
| Q2 2022 | $3,035,000 | -28.9% | 760,497 | -20.8% | 0.00% | 0.0% |
| Q1 2022 | $4,269,000 | +423.8% | 960,393 | +371.2% | 0.00% | – |
| Q4 2021 | $815,000 | -32.4% | 203,800 | +48.6% | 0.00% | – |
| Q3 2021 | $1,205,000 | +617.3% | 137,183 | +822.2% | 0.00% | – |
| Q2 2021 | $168,000 | -71.1% | 14,876 | -69.6% | 0.00% | – |
| Q1 2021 | $581,000 | -17.2% | 48,907 | -52.2% | 0.00% | – |
| Q4 2020 | $702,000 | -10.6% | 102,380 | -3.5% | 0.00% | – |
| Q3 2020 | $785,000 | +5507.1% | 106,041 | +3195.2% | 0.00% | – |
| Q2 2020 | $14,000 | -62.2% | 3,218 | -78.8% | 0.00% | – |
| Q1 2020 | $37,000 | -84.7% | 15,154 | -63.6% | 0.00% | – |
| Q4 2019 | $242,000 | +83.3% | 41,671 | +66.1% | 0.00% | – |
| Q3 2019 | $132,000 | +135.7% | 25,091 | +170.5% | 0.00% | – |
| Q2 2019 | $56,000 | -51.7% | 9,276 | -27.9% | 0.00% | – |
| Q1 2019 | $116,000 | +9.4% | 12,857 | +1.1% | 0.00% | – |
| Q4 2018 | $106,000 | -31.6% | 12,717 | +12.9% | 0.00% | – |
| Q3 2018 | $155,000 | +171.9% | 11,265 | +57.4% | 0.00% | – |
| Q2 2018 | $57,000 | +18.8% | 7,156 | +11.1% | 0.00% | – |
| Q1 2018 | $48,000 | +269.2% | 6,441 | +234.6% | 0.00% | – |
| Q4 2017 | $13,000 | +44.4% | 1,925 | +52.3% | 0.00% | – |
| Q3 2017 | $9,000 | +80.0% | 1,264 | +14.1% | 0.00% | – |
| Q2 2017 | $5,000 | -44.4% | 1,108 | -39.4% | 0.00% | – |
| Q1 2017 | $9,000 | -25.0% | 1,829 | -34.3% | 0.00% | – |
| Q1 2016 | $12,000 | – | 2,784 | +3934.8% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 69 | -95.7% | 0.00% | – |
| Q3 2015 | $9,000 | -40.0% | 1,589 | -17.3% | 0.00% | – |
| Q2 2015 | $15,000 | +650.0% | 1,922 | +819.6% | 0.00% | – |
| Q1 2015 | $2,000 | – | 209 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |